Stockscreener 앱 받기
1.22
2.52%
0.03
시간 외 거래:
1.20
-0.02
-1.64%
Inovio Pharmaceuticals Inc 주식(INO)의 최신 뉴스
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally - Stocktwits
Inovio Pharmaceuticals Inc. stock rises Monday, still underperforms market - MarketWatch
Inovio Pharmaceuticals, Inc.(NasdaqCM: INO) added to Russell 3000E Growth Benchmark - marketscreener.com
Inovio Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:INO) - TradingView
Price to earnings forward of Inovio Pharmaceuticals, Inc. – NASDAQ:INO - TradingView
Price to sales forward of Inovio Pharmaceuticals, Inc. – NASDAQ:INO - TradingView
Enterprise value to revenue forward of Inovio Pharmaceuticals, Inc. – NASDAQ:INO - TradingView
Inovio Pharmaceuticals, Inc. Actuals & Estimates (BX:GBM) - TradingView
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
INO stock edges up after hours as partner reports success in cervical dysplasia trial - MSN
Inovio Pharmaceuticals, Inc. Actuals & Estimates (DUS:GBM) - TradingView
Inovio Pharmaceuticals, Inc. Actuals & Estimates (BMV:INO) - TradingView
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
INO Forecast — Price Target — Prediction for 2027 - TradingView
Inovio Pharmaceuticals Inc (INO) Institutional Confidence - TradingKey
Is Inovio Pharmaceuticals (INO) a High-Stakes Bet Ahead of its October PDUFA Date - Kavout | AI
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Inovio Pharmaceuticals Inc (INO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Inovio Pharmaceuticals Inc (INO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Inovio Pharmaceuticals Inc (INO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Inovio Pharmaceuticals Inc (INO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Inovio Pharmaceuticals Inc (INO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inovio Pharmaceuticals Inc (INO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Inovio Pharmaceuticals Inc (INO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Inovio Pharmaceuticals Inc (INO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Q1 2026 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Q2 2025 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Glioblastoma Clinical Trial Landscape Expands: Over 200 Companies Advancing Next-Generation Therapies | DelveInsight - GlobeNewswire Inc.
Inovio Pharmaceuticals Faces Stock Dilution and Legal Battles - timothysykes.com
Inovio Pharmaceuticals(INO) Stock Options Chain | Quotes & News - Moomoo
Inovio Pharmaceuticals Inc Annual Shareholders Meeting Transcript - GuruFocus
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Anal Cancer Market to Witness Transformational Growth Opportunities by 2036 – DelveInsight | Incyte Corp, BioMimetix, Inovio Pharma, Merck Sharp & Dohme, Dustin Deming, Advaxis - Barchart.com
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm - PR Newswire
Inovio gains on late-stage trial win for DNA shot - MSN
INO Stock Price, Quote & Chart | INOVIO PHARMACEUTICALS INC (NASDAQ:INO) - ChartMill
Inovio Pharma Is Maintained at Neutral by HC Wainwright & Co. - Moomoo
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
Inovio Shares Fall After Analyst Cut, Traders Wait for FDA Decision - Bez Kabli
INO Maintained by HC Wainwright & Co. -- Price Target Lowered to $2.50 - GuruFocus
H.C. Wainwright lowers Inovio stock price target on share count - Investing.com UK
3.86%
자본화:
|
볼륨(24시간):